✦ LIBER ✦

Recurrent IDH mutations in high-risk myelodysplastic syndrome or acute myeloid leukemia with isolated del(5q)

✍ Scribed by Pardanani, A; Patnaik, M M; Lasho, T L; Mai, M; Knudson, R A; Finke, C; Ketterling, R P; McClure, R F; Tefferi, A

Book ID: 109887430
Publisher: Nature Publishing Group
Year: 2010
Tongue: English
Weight: 157 KB
Volume: 24
Category: Article
ISSN: 0887-6924
DOI: 10.1038/leu.2010.98

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute pulmonary failure during remission

Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndrome

✍ Ali Al Ameri; Charles Koller; Hagop Kantarjian; Farhad Ravandi; Srdan Verstovsek 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 2 views

Results of imatinib mesylate therapy in

Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders

✍ Jorge Cortes; Francis Giles; Susan O'Brien; Deborah Thomas; Maher Albitar; Mary 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

## Abstract ## BACKGROUND Imatinib mesylate is a selective tyrosine kinase inhibitor of c‐abl, bcr/abl, c‐kit, and platelet‐derived growth factor‐receptor (PDGF‐R). c‐kit is expressed in most patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) and PDGF has been implicated

Incidence of 17p deletions and TP53 muta

Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion

✍ Amel Sebaa; Lionel Ades; Fanny Baran-Marzack; Marie-Joelle Mozziconacci; Dominiq 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

A Phase II Study of Lenalidomide Alone i

A Phase II Study of Lenalidomide Alone in Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes With Chromosome 5 Abnormalities

✍ Yiming Chen; Hagop Kantarjian; Zeev Estrov; Stefan Faderl; Farhad Ravandi; Krist 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 214 KB

Intensive treatment strategies in patien

Intensive treatment strategies in patients with high-risk myelodysplastic syndrome and secondary acute myeloid leukemia

✍ M. Oosterveld; T. de Witte 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Limitations of targeted therapy with sor

Limitations of targeted therapy with sorafenib in elderly high-risk myelodysplastic syndrome and acute myeloid leukemia

✍ Wei, Andrew; Tan, Peter 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 143 KB